CovidVax show full list
COVID-19 VACCINE:

Whole - Virion Inactivated (COVAXIN) - BBV152

researcher:
Bharat Biotech
https://www.bharatbiotech.com/index.html
(India)
vaccine type: Inactivated virus
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)

PHASE 1-2

 

started July 13 2020

with 1125 healthy people aged 12-65

trial location: India

» clinical trial details

PHASE 1-2

 

started September 8 2020

with 124 healthy people aged 12-65

trial location: India

» clinical trial details

Nov 11Covaxin's third phase of clinical trials has started with AMU VC Professor Tariq Mansoor being the first volunteer for the trials (by livemint.com)
Sep 22Three Government Medical Colleges in Punjab will participate in COVAXIN's Phase 3 trials scheduled to begin Oct. 15 (by yahoo.com)
Sep 20COVAXIN's Phase 2 clinical trials began at PGI Rohtak on Wednesday with 50 volunteers (by republicworld.com)
Aug 19Bharat's Covaxin results of Phase 1/2 human trials are expected in India in a few weeks (by hindustantimes.com)
Jul 27Bharat's Covaxin vaccine showed encouraging results after Phase 1 human trials were completed (by deccanchronicle.com)
Animal Testing updates (pre-clinical trials)
Sep 11COVAXIN (BBV152) showed demonstration of protective efficacy and immunogenicity in non-human primates (by bharatbiotech.com)
Sep 10BBV152 demonstrated remarkable immunogenicity and protective efficacy in rhesus macaques (by researchsquare.com)
early development updates
currently no early development info






contact | about | ©2020 CovidVax.org project